Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
21491979	s-prlbio	mu/l (mu/l)	1646	2327	0.00%
21491979	s-prlbio	— (—)	108	114	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Exclusions for E4_PCOS_CONSORTIUM

746

690

6.87

307.65

1.7

1.2

995.45

371.87

mu/l

3.53

712

651

Disorders of other endocrine glands

733

508

14.62

307.65

1.7

1.2

1043.66

375.77

mu/l

3.87

710

474

Exclusions for E4_PCOS_BROAD

685

165

45.30

307.65

1.8

1.2

1110.54

347.52

mu/l

4.26

661

156

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

505

350

14.85

307.65

1.7

1.4

1086.10

431.69

mu/l

2.15

491

329

Endocrine, nutritional and metabolic diseases

527

533

5.04

186.08

1.6

1.1

597.21

356.12

mu/l

3.27

507

498

Female infertility

298

283

6.49

144.92

1.3

1.5

348.06

810.65

mu/l

4.68

286

268

Female infertility, cervical, vaginal, other or unspecified origin

265

270

6.48

133.23

1.3

1.5

313.99

832.49

mu/l

5.29

254

255

Kela-code for severe mental illness

286

587

4.93

129.90

1.5

1.4

795.41

479.66

mu/l

2.70

264

560

Schizophrenia or delusion, excluding more controls

239

426

5.62

125.36

1.4

1.5

834.36

505.25

mu/l

3.09

220

412

Unspecified mental disorder

304

689

4.46

122.21

1.5

1.4

788.16

468.93

mu/l

3.18

280

660

Anxiety (asthma-related co-morbidities)

396

835

3.70

114.61

1.4

1.5

615.57

539.32

mu/l

0.34

371

805

Used for control exclusion in common control thyroid runs

523

805

3.30

110.64

1.6

1.2

965.07

492.73

mu/l

1.31

496

762

Depression

488

1075

3.09

103.47

1.4

585.26

714.38

mu/l

0.51

460

1031

Mood disorders

506

1083

3.04

102.73

1.4

577.36

713.11

mu/l

0.55

473

1038

Mood [affective] disorders

504

1083

3.03

101.98

1.4

576.32

712.91

mu/l

0.55

471

1038

Schizophrenia or delusion

239

521

4.64

101.06

1.4

1.5

834.36

450.53

mu/l

5.65

220

500

Schizophrenia, schizotypal and delusional disorders

239

522

4.63

100.83

1.4

1.5

834.36

449.28

mu/l

5.69

220

501

All anxiety disorders

408

1014

3.20

95.77

1.4

613.80

490.50

mu/l

1.06

383

968

Other and unspecified nonorganic psychotic disorders

192

366

5.33

95.22

1.5

1.4

836.79

386.41

mu/l

9.53

174

349

Irregular menses

353

819

3.44

92.34

1.5

1.4

514.42

564.42

mu/l

0.47

334

778

Mood disorders, excluding more controls

430

808

3.19

92.16

1.4

1.5

538.34

780.72

mu/l

0.89

399

776

Hypothyroidism (congenital or acquired)

242

290

4.76

85.04

1.6

1.4

562.85

522.46

mu/l

0.11

226

276

Anxiety disorders, excluding more controls

385

797

3.16

83.58

1.4

1.5

555.97

784.87

mu/l

0.79

362

766

Neurotic, stress-related and somatoform disorders

446

1106

2.84

82.43

1.4

588.77

681.96

mu/l

0.34

416

1056

Anxiety disorders

447

1108

2.82

81.99

1.4

588.77

710.93

mu/l

0.47

416

1059

Hypothyroidism and >3 levothyroxin purchases

237

290

4.67

81.56

1.6

1.4

566.77

522.46

mu/l

0.12

221

276

Hypothyroidism, levothyroxine purchases

237

290

4.67

81.56

1.6

1.4

566.77

522.46

mu/l

0.12

221

276

Polycystic ovarian syndrome, consortium definition

419

852

2.93

77.99

1.5

1.4

483.85

566.38

mu/l

1.05

400

811

Disorders of the thyroid gland

443

1060

2.73

75.13

1.5

1.4

657.91

666.10

mu/l

0.02

414

1015

Hypothyroidism, other/unspecified

426

1020

2.76

73.73

1.6

1.4

630.55

673.75

mu/l

0.11

399

977

Hypothyreosis and Thyroxine purchase for inclusion criteria

434

1050

2.72

73.29

1.6

1.4

623.37

686.12

mu/l

0.17

407

1003

Other anxiety disorders

324

924

3.06

72.55

1.4

657.11

484.78

mu/l

1.34

304

882

Personality disorders, excluding more controls

198

491

4.07

70.99

1.4

1.5

613.90

496.89

mu/l

0.45

184

471

Schizophrenia

115

186

6.26

67.86

1.5

887.80

361.17

mu/l

6.51

103

181

Acute and transient psychotic disorders

133

6.87

57.99

1.4

1.5

951.02

382.04

mu/l

5.11

128

Disorders of adult personality and behaviour

218

677

3.25

56.01

1.4

1.5

601.22

483.98

mu/l

0.60

202

648

Noninflammatory disorders of female genital tract

246

359

3.46

55.97

1.4

1.5

385.31

742.25

mu/l

4.22

233

340

Medical observation and evaluation for suspected diseases and conditions

289

490

3.03

54.30

1.4

452.61

886.23

mu/l

1.14

271

470

Benign neoplasms

443

1049

2.34

52.41

1.6

1.3

1012.26

458.60

mu/l

1.44

430

983

Personality disorders

198

616

3.25

50.77

1.4

1.5

613.90

493.92

mu/l

0.55

184

593

Bipolar affective disorders

140

355

3.99

48.90

1.4

617.84

466.48

mu/l

0.91

129

343

Benzodiazepine use

393

1226

2.21

43.76

1.3

1.4

624.11

693.82

mu/l

0.25

368

1170

Specific personality disorders

173

546

3.20

43.42

1.4

497.05

484.56

mu/l

0.08

160

526

Headache

304

1004

2.43

43.24

1.4

538.80

709.88

mu/l

0.66

291

958

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

172

542

3.18

42.89

1.4

1.5

664.88

480.63

mu/l

1.39

158

524

Other antidepressants

372

849

2.25

39.85

1.4

486.53

775.15

mu/l

1.24

350

808

Migraine

278

948

2.39

38.37

1.4

495.27

527.77

mu/l

0.26

269

900

Recurrent or chronic depression

183

428

3.02

38.24

1.3

1.5

424.88

545.89

mu/l

0.78

174

414

Any mental disorder

362

812

2.24

38.05

1.4

1.5

487.81

778.06

mu/l

1.17

340

780

Other nutritional deficiencies

288

1206

2.26

36.06

1.5

1.4

437.70

695.83

mu/l

1.80

276

1148

Hirsutism in women

9.05

34.31

1.2

1.4

394.88

396.30

mu/l

0.01

Selective serotonin reuptake inhibitors

352

856

2.15

34.24

1.5

1.4

496.60

770.41

mu/l

1.05

335

815

Ovarian dysfunction

195

4.44

34.15

1.4

1.3

386.38

397.10

mu/l

0.07

182

Emotionally unstable personality disorder

119

348

3.47

33.96

1.4

518.58

494.99

mu/l

0.12

109

330

Mixed and other personality disorders

124

5.32

32.46

1.3

1.5

935.85

449.64

mu/l

0.89

118

Poisoning by medicine

139

460

3.05

32.32

1.3

1.4

685.78

457.92

mu/l

2.05

130

441

Substance abuse, excluding more controls

192

631

2.60

32.25

1.3

1.5

583.23

869.82

mu/l

0.78

177

605

Obesity

269

1180

2.21

32.16

1.5

1.4

434.68

695.43

mu/l

1.76

257

1124

Obesity and other hyperalimentation

269

1180

2.20

32.04

1.5

1.4

434.68

695.43

mu/l

1.76

257

1124

Examination and observation for other reasons

216

489

2.56

31.78

1.5

1.4

418.68

887.55

mu/l

1.29

206

469

Hypertrichosis

7.94

31.68

1.2

1.4

389.16

436.62

mu/l

0.24

Other disorders of fluid, electrolyte and acid-base balance

179

4.33

31.44

1.2

1.5

545.89

741.54

mu/l

0.26

171

Hypothyroidism, strict autoimmune

250

706

2.34

31.39

1.4

1.2

479.49

459.72

mu/l

0.14

228

669

Depression medications

175

305

2.90

30.70

1.3

1.4

455.28

514.17

mu/l

0.33

164

291

Excessive, frequent and irregular menstruation

175

343

2.81

29.97

1.4

1.5

468.15

757.31

mu/l

2.31

164

324

Poisoning by drugs, medicaments and biological substances

143

507

2.84

29.42

1.3

1.5

676.92

460.01

mu/l

1.99

133

487

Neoplasms

365

973

1.99

29.36

1.6

1.3

661.56

461.72

mu/l

1.39

357

911

Polycystic ovarian syndrome

156

4.59

29.25

1.4

1.2

338.91

406.84

mu/l

0.76

145

General examination and investigation of persons without complaint and reported diagnosis

227

490

2.42

28.97

1.4

516.30

886.23

mu/l

0.90

216

470

Psychiatric diseases

302

722

2.10

27.45

1.4

1.5

482.37

810.17

mu/l

1.18

283

694

Episodal and paroxysmal disorders

398

1090

1.86

26.12

1.5

1.4

481.02

657.03

mu/l

1.04

377

1032

Malaise and fatigue

163

516

2.55

26.06

1.4

1.5

447.78

819.58

mu/l

1.00

156

494

Other symptoms and signs involving cognitive functions and awareness

112

334

3.06

25.94

1.3

1.4

421.41

888.42

mu/l

0.77

105

316

Genitourinary diseases

203

419

2.44

25.91

1.4

1.5

469.52

1058.12

mu/l

1.20

194

398

Panic disorder

110

364

3.05

25.72

1.4

1.5

825.49

474.05

mu/l

1.06

104

348

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

172

717

2.41

25.56

1.4

1.5

664.88

481.16

mu/l

1.87

158

686

Nonorganic sleeping disorders, excluding more controls

100

324

3.11

24.23

1.5

540.98

440.46

mu/l

0.49

312

Persons encountering health services for other counselling and medical advice, not elsewhere classified

366

1075

1.85

24.17

1.4

1.5

657.80

700.24

mu/l

0.10

349

1018

Symptoms and signs involving cognition, perception, emotional state and behaviour

315

1127

1.91

23.98

1.3

1.5

668.74

716.68

mu/l

0.11

304

1063

Other and unspecified mood [affective] disorders

161

4.10

23.71

1.4

1.5

799.42

403.73

mu/l

1.93

153

Substance use, excluding alcohol

324

3.08

23.59

1.3

1.5

599.77

454.16

mu/l

1.15

308

Suicide or other Intentional self-harm

124

465

2.68

23.03

1.4

1.5

746.03

430.64

mu/l

3.36

114

445

Mental and behavioural disorders due to sedatives or hypnotics

5.07

22.80

1.3

1.4

551.56

399.79

mu/l

0.76

Depression or dysthymia

198

482

2.27

22.50

1.4

1.5

375.66

976.31

mu/l

1.71

189

465

Caries of enamel

322

1264

1.84

22.26

1.4

580.01

699.52

mu/l

0.38

302

1205

Pain and other conditions associated with female genital organs and menstrual cycle

102

323

2.92

21.81

1.3

1.5

451.19

776.02

mu/l

2.50

304

Persons encountering health services in other circumstances, wide

373

1077

1.79

21.67

1.4

612.68

699.97

mu/l

0.24

357

1020

Visual disturbances and blindness

167

742

2.26

21.45

1.5

1.4

639.15

698.38

mu/l

0.11

160

705

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

101

359

2.84

20.86

1.3

1.4

737.61

418.51

mu/l

3.84

343

Phobic anxiety disorders

344

2.87

20.67

1.3

1.4

546.14

470.99

mu/l

0.42

329

Metabolic disorders

265

836

1.94

20.64

1.3

1.5

841.23

666.60

mu/l

0.19

252

799

Special screening examination for infectious and parasitic diseases

139

415

2.48

20.61

1.5

1.4

549.03

519.36

mu/l

0.07

126

397

Behavioural syndromes associated with physiological disturbances and physical factors

325

1289

1.79

20.53

1.4

567.31

676.10

mu/l

0.50

306

1226

Diarrhoea and gastroenteritis of presumed infectious origin

339

1267

1.77

20.17

1.4

587.36

655.90

mu/l

0.20

319

1204

Neurological diseases

325

902

1.81

19.78

1.5

1.4

465.17

669.66

mu/l

1.03

309

858

Sleep disorders

312

1266

1.78

19.56

1.5

1.4

550.59

654.02

mu/l

0.47

297

1203

Post-traumatic stress disorder

245

3.18

19.40

1.3

1.4

482.77

505.16

mu/l

0.08

232

General symptoms and signs

361

1040

1.74

19.24

1.4

461.10

725.85

mu/l

1.48

341

992

Pain, not elsewhere classified

105

400

2.64

18.97

1.4

1.5

752.75

496.34

mu/l

0.66

383

Sleep disorders (combined)

365

1119

1.71

18.65

1.5

1.4

636.56

691.90

mu/l

0.11

346

1065

Substance abuse

192

893

2.03

18.58

1.3

1.5

583.23

748.51

mu/l

0.55

177

849

Mental and behavioural disorders due to psychoactive substance use

197

918

1.99

18.20

1.3

1.4

575.90

743.93

mu/l

0.59

182

873

Implicit Sepsis

194

730

2.01

17.62

1.3

1.5

682.88

748.06

mu/l

0.11

184

699

Obesity due to excess calories

181

899

2.02

17.59

1.4

445.46

710.92

mu/l

1.27

173

860

Anaemias

107

266

2.64

17.49

1.3

1.4

449.56

521.29

mu/l

0.38

100

254

Visual disturbances

151

704

2.15

17.37

1.5

1.4

643.81

711.17

mu/l

0.12

144

672

Procreative management

155

602

2.16

17.28

1.4

1.5

610.05

585.90

mu/l

0.04

147

574

Insomnia

308

1304

1.72

17.27

1.4

553.44

656.51

mu/l

0.47

292

1236

Disorders of lipoprotein metabolism and other lipidaemias

160

458

2.17

16.94

1.4

1.6

1199.31

690.93

mu/l

0.37

151

436

Sleep apnoea

231

799

1.87

16.68

1.5

1.4

701.74

782.08

mu/l

0.11

222

757

Intestinal infectious diseases

312

1402

1.69

16.48

1.3

1.4

669.21

653.56

mu/l

0.04

295

1333

Implicit Sepsis

222

867

1.87

16.46

1.4

1.5

671.47

730.05

mu/l

0.11

209

826

Use of hypnotics and sedatives

306

1020

1.73

16.40

1.3

1.5

677.62

730.14

mu/l

0.13

289

971

Other special examinations and investigations of persons without complaint or reported diagnosis

193

491

1.99

15.68

1.4

442.67

884.74

mu/l

1.18

181

471

Disorders of skin appendages

193

1022

1.89

15.58

1.3

1.5

501.61

520.99

mu/l

0.12

184

972

Alcohol dependence

260

2.82

15.11

1.2

1.5

530.87

1083.00

mu/l

0.67

247

Condition for Implicit Sepsis (Organ dysfunction codes)

230

901

1.80

15.06

1.3

1.5

762.98

702.30

mu/l

0.11

216

859

Pure hypercholesterolaemia

127

369

2.25

14.98

1.4

1.6

1626.69

664.61

mu/l

0.61

122

355

Dental caries

308

2.60

14.60

1.5

482.35

535.29

mu/l

0.23

290

Other headache syndromes

143

703

2.04

14.36

1.4

463.15

560.17

mu/l

0.90

137

666

Non-selective monoamine reuptake inhibitors

257

2.74

14.31

1.2

1.6

544.92

700.25

mu/l

0.27

245

Problems related to lifestyle

168

3.24

14.19

1.4

1.5

655.80

388.11

mu/l

1.83

159

Nonorganic sleeping disorders

100

429

2.34

14.19

1.5

1.4

540.98

479.64

mu/l

0.28

410

Other disorders of lacrimal gland

405

2.38

14.12

1.4

1.5

376.95

456.52

mu/l

1.13

383

Sleep apnoea, including avohilmo

254

911

1.73

14.06

1.5

1.4

699.72

747.70

mu/l

0.07

245

863

Pain in joint

181

610

1.90

13.59

1.5

1.4

488.70

735.81

mu/l

1.09

173

579

Caries of dentine

275

2.63

13.37

1.5

487.33

530.30

mu/l

0.16

259

Hypothyroidism, strict autoimmune, 3 medication purchases required

247

989

1.69

12.86

1.4

479.81

696.77

mu/l

1.03

225

943

Alcohol use disorder, Swedish definition

151

727

1.91

12.47

1.3

1.5

601.04

769.87

mu/l

0.43

137

691

Alcohol use disorder, ICD-based

116

560

2.08

12.35

1.2

1.4

569.70

896.50

mu/l

0.77

103

533

Oedema, not elsewhere classified

303

2.48

12.30

1.3

1.5

531.94

541.41

mu/l

0.02

290

Antihypertensive medication - note that there are other indications

296

977

1.61

12.17

1.4

528.17

520.90

mu/l

0.05

281

927

Mental and behavioural disorders due to alcohol, excluding acute intoxication

123

610

2.01

12.01

1.2

1.5

575.45

847.00

mu/l

0.66

110

577

Convulsions, not elsewhere classified

405

2.25

11.96

1.3

1.5

481.81

485.74

mu/l

0.02

390

Intestinal infectious diseases

337

1246

1.55

11.94

1.4

735.20

658.66

mu/l

0.18

321

1184

Any reimbursement code in KELA

250

751

1.67

11.77

1.5

1.4

480.12

585.79

mu/l

0.55

238

719

Triptan medication for migraine, single purchase ok

279

1185

1.60

11.74

1.4

517.21

534.77

mu/l

0.06

267

1126

Migraine, single triptan purchase ok & required. ICD-code if available is included

279

1185

1.60

11.74

1.4

517.21

534.77

mu/l

0.06

267

1126

Condition for Implicit Sepsis (Organ dysfunction codes)

252

1063

1.64

11.73

1.4

1.5

806.67

665.75

mu/l

0.30

238

1010

Diarrhoea and gastroenteritis of presumed infectious origin

235

1289

1.64

11.68

1.3

1.4

501.93

644.85

mu/l

0.80

222

1223

Disorders of lacrimal system

109

526

2.07

11.56

1.4

1.5

383.48

464.94

mu/l

1.31

104

498

Other functional intestinal disorders

120

558

2.00

11.42

1.2

1.5

698.19

796.23

mu/l

0.18

107

534

Mental and behavioural disorders due to alcohol

145

748

1.87

11.35

1.2

1.5

547.65

798.10

mu/l

0.78

132

713

Symptoms and signs involving the circulatory and respiratory systems

346

1136

1.53

11.31

1.5

1.4

490.76

638.67

mu/l

1.15

325

1082

Other/unspecified dorsalgia

110

535

2.04

11.25

1.4

510.13

587.70

mu/l

0.24

103

507

170

845

1.77

11.14

1.3

1.4

582.62

748.46

mu/l

0.50

156

803

Tramadol

219

803

1.68

11.00

1.4

620.30

790.67

mu/l

0.43

211

764

Diseases of male genital organs

114

273

2.11

10.91

1.4

639.04

1287.84

mu/l

0.69

104

259

Irritable bowel syndrome

467

2.11

10.87

1.4

1.5

540.92

502.74

mu/l

0.19

447

Care involving use of rehabilitation procedures

164

851

1.78

10.84

1.4

526.56

826.71

mu/l

1.21

158

811

Mycoses

261

1445

1.57

10.79

1.5

1.4

941.06

610.69

mu/l

0.40

245

1375

Triptan medication for migraine, min. 3 purchases

240

1142

1.61

10.63

1.5

1.4

606.07

526.39

mu/l

0.29

230

1087

Polyp of the female genital tract

161

2.54

10.61

1.3

1.6

491.18

795.93

mu/l

1.37

152

Hypertrophy of breast in women and men

294

2.39

10.53

1.4

1.5

445.53

418.45

mu/l

0.15

281

158

808

1.77

10.34

1.2

1.4

543.56

774.84

mu/l

0.77

145

770

Heart failure, not strict

119

412

1.96

10.19

1.5

1066.14

850.85

mu/l

0.19

113

394

KRA_PSY_EATING, excluding more controls

274

2.42

10.12

1.2

1.5

558.63

448.47

mu/l

0.48

263

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

144

713

1.81

10.02

1.3

1.4

563.13

476.86

mu/l

0.80

134

677

Renal failure

264

2.35

9.93

1.3

884.84

1114.76

mu/l

0.17

251

Endometriosis

276

2.11

9.89

1.2

1.5

359.02

824.64

mu/l

4.14

261

Dorsalgia

321

1152

1.49

9.69

1.5

1.4

793.79

622.04

mu/l

0.24

308

1088

Fever of other and unknown origin

152

774

1.75

9.61

1.4

1.5

802.35

803.51

mu/l

0.00

141

739

Dental pulpitis, including avohilmo

307

1341

1.49

9.44

1.4

646.23

676.29

mu/l

0.05

286

1278

Dentofacial anomalies [including malocclusion]

244

1268

1.55

9.37

1.4

567.67

527.35

mu/l

0.17

236

1202

Asthma, hospital admission 2, infections

171

1002

1.67

9.33

1.5

1.4

494.14

704.48

mu/l

1.00

163

950

Asthma-related infections

171

1002

1.67

9.33

1.5

1.4

494.14

704.48

mu/l

1.00

163

950

Low back pain

236

1087

1.56

9.24

1.5

1.4

1005.08

631.14

mu/l

0.41

226

1026

Lower back pain or/and sciatica

306

1353

1.48

9.16

1.5

1.4

887.60

619.06

mu/l

0.37

295

1280

Dermatitis and eczema

320

1357

1.46

9.01

1.5

1.4

545.19

693.03

mu/l

0.79

304

1287

Social phobias

218

2.50

8.94

1.3

1.4

521.06

429.60

mu/l

0.53

208

Neurological diseases, wide definition

141

394

1.80

8.73

1.4

1.3

421.03

652.92

mu/l

1.76

132

376

Certain disorders involving the immune mechanism

185

2.60

8.72

1.5

488.29

464.56

mu/l

0.10

178

Persons encountering health services for examination and investigation

167

491

1.71

8.66

1.4

421.76

884.74

mu/l

1.27

162

471

Type 2 diabetes

260

1004

1.51

8.59

1.3

1.5

548.77

655.64

mu/l

0.46

245

960

147

859

1.70

8.58

1.5

1.4

476.99

537.21

mu/l

0.46

140

814

Menorrhagia

213

2.14

8.46

1.4

1.5

536.00

804.68

mu/l

1.14

201

Asthma (mode)

235

816

1.54

8.34

1.5

492.78

718.35

mu/l

1.33

226

782

Syncope and collapse

103

469

1.88

8.27

1.3

1.5

901.90

844.44

mu/l

0.05

450

Gastroduodenal ulcer

129

2.87

8.09

1.4

1.5

578.37

603.13

mu/l

0.04

124

Cystitis

255

1014

1.50

8.04

1.5

1.4

587.57

710.32

mu/l

0.39

236

970

Emotional disorders and disorders of social functioning with onset specific to childhood

184

2.54

8.04

1.2

1.4

599.86

413.05

mu/l

1.11

174

Acute upper respiratory infections of multiple and unspecified sites

238

1178

1.50

7.88

1.4

474.90

591.10

mu/l

1.04

230

1115

Abnormalities of breathing

284

1132

1.46

7.87

1.5

1.4

451.21

639.43

mu/l

1.83

270

1079

Acute pancreatitis

154

2.67

7.87

1.2

1.4

554.87

451.29

mu/l

0.21

147

Acute pancreatitis (for exclusion)

154

2.67

7.87

1.2

1.4

554.87

453.63

mu/l

0.21

148

Disorders of optic nerve and visual pathways

132

2.82

7.84

1.5

1152.29

405.37

mu/l

0.56

127

Dialysis, with operation codes

3.31

7.78

1.4

1.5

684.32

383.83

mu/l

1.63

Candidiasis

522

1.86

7.76

1.5

1.4

483.70

493.05

mu/l

0.04

500

Disorders of conjunctiva

256

1403

1.47

7.71

1.4

603.61

661.57

mu/l

0.23

246

1331

Asthma, excluding more controls

233

804

1.51

7.55

1.5

502.45

643.35

mu/l

0.79

224

771

Asthma

234

814

1.51

7.50

1.5

501.40

719.11

mu/l

1.25

225

780

Other disorders of eye and adnexa

200

2.41

7.47

1.2

1.4

431.86

430.42

mu/l

0.01

191

Complications of medical and surgical care

174

1018

1.57

7.45

1.3

1.5

514.63

725.58

mu/l

0.91

162

975

Opioids

316

1157

1.42

7.44

1.4

450.98

691.98

mu/l

1.49

299

1099

Hypertensive diseases (excluding secondary)

158

560

1.64

7.41

1.4

1.5

517.60

592.88

mu/l

0.40

153

534

Diaphragmatic hernia

251

2.23

7.37

1.4

1.5

462.31

890.38

mu/l

0.54

239

Other dorsopathies, not elsewhere classified

314

1161

1.42

7.32

1.5

1.4

765.15

620.63

mu/l

0.19

300

1097

Type 2 diabetes, strict (exclude DM1)

227

888

1.50

7.32

1.3

1.5

578.94

657.32

mu/l

0.26

211

848

Type 2 diabetes, definitions combined

227

888

1.50

7.31

1.3

1.5

578.94

655.46

mu/l

0.25

211

848

Conjunctivitis

239

1364

1.47

7.24

1.4

617.07

627.09

mu/l

0.03

230

1296

Other neurological diseases

134

629

1.68

7.23

1.5

945.71

737.93

mu/l

0.23

129

598

Disorders of ocular muscles, binocular movement, accommodation and refraction

159

994

1.59

7.18

1.3

1.4

540.87

500.38

mu/l

0.27

148

947

Diseases of the skin and subcutaneous tissue

289

1012

1.43

7.14

1.4

520.78

616.09

mu/l

0.40

274

965

Type 2 diabetes, definitions combined, including avohilmo

232

910

1.49

7.10

1.3

1.5

568.38

663.64

mu/l

0.34

216

870

Persons encountering health services in other circumstances

121

712

1.69

7.06

1.2

1.5

609.80

591.80

mu/l

0.05

115

673

Codeine

290

1108

1.42

7.02

1.4

577.23

699.03

mu/l

0.41

272

1052

Diseases of the eye and adnexa

282

988

1.43

6.92

1.5

1.4

568.64

585.00

mu/l

0.05

268

933

Hypertension, essential

175

631

1.57

6.88

1.3

1.5

465.48

575.05

mu/l

0.76

169

599

Exposure to unspecified factor

283

1446

1.41

6.84

1.3

1.4

543.68

681.60

mu/l

0.72

272

1371

Use of pramipexole

137

2.63

6.78

1.7

1.4

715.67

428.78

mu/l

0.59

131

Pain (limb, back, neck, head abdominally)

192

625

1.54

6.76

1.2

1.4

444.56

725.42

mu/l

1.47

185

593

Other soft tissue disorders, not elsewhere classified

289

1205

1.41

6.68

1.4

465.10

725.31

mu/l

1.69

276

1146

Benign neoplasm of other and ill-defined parts of digestive system

110

2.83

6.66

1.2

1.4

587.45

440.09

mu/l

0.69

105

Symptoms and signs involving the skin and subcutaneous tissue

179

1159

1.51

6.55

1.4

548.61

717.73

mu/l

0.74

173

1099

Type 2 diabetes, wide definition

133

518

1.64

6.49

1.3

1.5

1375.85

716.09

mu/l

0.41

124

490

Hypertension

183

676

1.53

6.42

1.4

1.5

477.66

561.01

mu/l

0.57

178

643

Hypertensive diseases

183

677

1.53

6.39

1.4

1.5

477.66

562.82

mu/l

0.59

178

644

Asthma, including avohilmo

335

1382

1.36

6.37

1.4

514.03

695.61

mu/l

1.09

324

1308

Hyperfunction of pituitary gland, other and/or unspecified

+∞

6.35

2.0

0.0

189.67

—

mu/l

—

Mouth breathing

462

1.82

6.32

1.5

1.4

349.78

849.87

mu/l

1.28

440

Constipation

188

869

1.50

6.26

1.3

1.5

756.14

730.92

mu/l

0.05

169

834

Autoimmune diseases

329

1227

1.36

6.21

1.5

1.4

745.62

659.10

mu/l

0.11

311

1168

Parasetamol

255

907

1.43

6.21

1.4

438.33

782.89

mu/l

1.80

247

859

Certain infectious and parasitic diseases

282

1009

1.40

6.20

1.4

436.50

698.15

mu/l

1.44

270

956

Other and unspecified effects of external causes

100

588

1.71

6.04

1.4

601.13

488.40

mu/l

0.50

562

Cutaneous abscess, furuncle and carbuncle

427

1.83

6.02

1.3

1.4

462.22

410.81

mu/l

0.21

408

Diabetes mellitus

276

1162

1.39

5.99

1.3

1.5

552.06

627.16

mu/l

0.33

261

1108

Dorsopathies

313

1168

1.36

5.89

1.5

1.4

477.32

617.86

mu/l

1.15

300

1104

Symptoms and signs involving the urinary system

154

764

1.54

5.89

1.4

1.5

509.86

770.11

mu/l

0.88

141

732

Codeine or tramadol medication

314

1265

1.36

5.89

1.4

566.70

664.26

mu/l

0.36

295

1203

Diabetes, varying definitions

273

1156

1.39

5.85

1.3

1.5

554.27

628.49

mu/l

0.32

258

1102

Asthma (only as main-diagnosis)

205

814

1.46

5.82

1.5

501.69

719.11

mu/l

1.27

195

780

Asthma (only as main-diagnosis), excluding more controls

205

804

1.46

5.81

1.5

501.69

643.35

mu/l

0.82

195

771

Dermatitis

147

957

1.53

5.78

1.5

1.4

559.11

750.24

mu/l

0.70

142

907

Dysphagia

212

2.17

5.75

1.3

1.5

538.22

527.98

mu/l

0.03

204

Complications of procedures, not elsewhere classified

197

1127

1.45

5.73

1.3

1.5

504.87

761.20

mu/l

1.35

183

1078

Chronic periodontitis, complicated

511

1.73

5.68

1.3

1.5

463.44

896.05

mu/l

1.10

487

Other diseases of intestines

317

1340

1.35

5.66

1.3

1.4

491.49

704.42

mu/l

1.45

293

1283

Disorders of breast

142

838

1.54

5.66

1.4

1.5

597.54

564.38

mu/l

0.08

136

801

Excessive attrition of teeth

171

1160

1.48

5.65

1.4

466.19

689.54

mu/l

1.27

159

1100

Persons encountering health services for specific procedures and health care

304

1349

1.35

5.64

1.4

600.21

687.22

mu/l

0.32

292

1279

Other diseases of liver

163

2.34

5.63

1.2

1.4

381.53

424.56

mu/l

0.17

157

Atopic dermatitis

207

1188

1.43

5.62

1.5

1.4

493.55

526.76

mu/l

0.25

197

1126

Dermatophytosis

155

1034

1.50

5.53

1.6

1.4

1153.52

671.47

mu/l

0.34

142

985

Follicular cysts of skin and subcutaneous tissue

184

2.23

5.49

1.5

597.95

424.31

mu/l

0.43

176

Bronchitis

294

1373

1.35

5.45

1.4

464.47

711.12

mu/l

1.82

282

1302

Lumbar disc prolapse

144

723

1.53

5.43

1.5

699.97

676.59

mu/l

0.03

137

682

Other disorders of skin and subcutaneous tissue

136

785

1.54

5.43

1.5

1216.45

609.44

mu/l

0.40

130

748

Transport accidents

152

870

1.51

5.42

1.3

1.5

1032.70

623.96

mu/l

0.28

143

829

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

119

367

1.63

5.38

1.3

1.4

432.87

843.00

mu/l

1.38

112

355

Cervical disc disorders

296

1.93

5.21

1.9

1.5

411.64

752.04

mu/l

0.88

281

Nutritional anaemias

554

1.65

5.19

1.3

1.5

1449.89

487.44

mu/l

0.46

527

Statin medication

183

708

1.45

5.15

1.4

1.5

540.82

574.15

mu/l

0.12

178

669

Pain in throat and chest

230

994

1.39

5.13

1.4

876.19

671.53

mu/l

0.20

217

948

Injuries to the neck

443

1.74

5.10

1.3

1.4

503.65

475.96

mu/l

0.13

424

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

239

1200

1.37

5.09

1.4

1200.77

603.81

mu/l

0.73

228

1139

Inflammatory diseases of female pelvic organs

201

1047

1.41

5.08

1.4

467.00

554.85

mu/l

0.85

187

1002

Eating disorder

363

1.83

5.08

1.2

1.4

558.63

506.76

mu/l

0.21

345

Gastro-oesophageal reflux disease

138

788

1.51

5.07

1.3

1.5

1149.84

674.91

mu/l

0.30

133

755

Eating disorders

378

1.81

5.06

1.2

1.4

549.44

499.12

mu/l

0.21

360

Other (not insulin) diabetes medications

221

939

1.40

5.06

1.4

1.5

545.94

798.44

mu/l

0.90

204

898

Melanocytic naevi of trunk

162

2.23

4.83

1.6

1.5

2814.08

408.83

mu/l

0.46

157

Symptoms and signs involving the digestive system and abdomen

256

945

1.36

4.80

1.3

1.4

450.33

793.05

mu/l

1.85

236

906

Abnormalities of heart beat

501

1.67

4.80

1.4

575.32

653.66

mu/l

0.21

482

Diseases of liver

341

1.82

4.79

1.4

1.5

394.22

920.33

mu/l

0.91

324

Infections with a predominantly sexual mode of transmission

175

1148

1.42

4.78

1.3

1.4

418.39

532.98

mu/l

1.64

167

1088

Biguanides

205

894

1.40

4.77

1.3

1.5

527.90

807.49

mu/l

0.97

189

857

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

127

831

1.51

4.75

1.2

1.5

562.94

715.94

mu/l

0.44

119

793

Abdominal and pelvic pain

255

945

1.36

4.75

1.4

446.44

793.05

mu/l

1.88

236

906

Diseases of the digestive system

527

1.64

4.70

1.6

1.4

567.93

823.90

mu/l

0.55

501

Other diseases of urinary system

263

1103

1.34

4.66

1.4

575.76

709.19

mu/l

0.47

249

1056

Strabismus

477

1.68

4.65

1.4

654.61

480.33

mu/l

0.98

458

Alcohol abuse, main dg, excluding more controls

178

2.14

4.64

1.3

1.5

469.70

354.60

mu/l

0.52

173

Iron deficiency anaemia

513

1.63

4.50

1.3

1.5

438.88

492.50

mu/l

0.40

487

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

122

794

1.49

4.37

1.3

1.5

1343.76

613.35

mu/l

0.44

116

755

Complications of surgical and medical care, not elsewhere classified

242

1241

1.34

4.37

1.3

1.4

522.54

725.56

mu/l

1.07

227

1180

Congenital malformations, deformations and chromosomal abnormalities

206

1401

1.36

4.28

1.3

1.4

738.98

612.88

mu/l

0.30

198

1328

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

166

1152

1.40

4.26

1.4

620.35

540.53

mu/l

0.44

158

1099

Dyspnoea

201

1090

1.36

4.21

1.6

1.4

484.74

754.57

mu/l

1.54

191

1037

Trigeminal neuralgia

3.27

4.18

1.4

1.7

541.47

473.98

mu/l

0.14

Pain in limb

230

1152

1.34

4.17

1.5

1.4

480.27

737.91

mu/l

1.52

219

1094

Dipeptidyl peptidase 4 (DPP-4) inhibitors

295

1.74

4.15

1.2

1.5

763.00

1238.70

mu/l

0.44

283

Acute upper respiratory infections

260

1223

1.31

4.06

1.4

1077.09

594.76

mu/l

0.59

251

1159

Endometriosis diagnosis and infertility diagnosis occurring together

216

1.95

4.05

1.2

1.6

290.45

489.74

mu/l

4.20

206

Asthma (diagnoses ohter than nonallergic)

229

1435

1.32

4.04

1.5

1.4

492.33

695.30

mu/l

1.31

219

1364

Other metabolic disorders

163

2.09

3.96

1.2

1.5

478.06

429.73

mu/l

0.17

157

Postprocedural endocrine and metabolic disorders, not elsewhere classified

150

2.14

3.95

1.2

1.4

496.28

433.82

mu/l

0.22

144

Erysipelas

122

634

1.47

3.94

1.4

1.5

504.92

824.55

mu/l

0.89

116

599

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

115

781

1.47

3.89

1.2

1.5

510.84

728.75

mu/l

0.70

109

743

First line medication for Crohn's disease

307

1300

1.28

3.88

1.5

1.4

492.78

706.14

mu/l

1.31

298

1228

Infections of the skin and subcutaneous tissue

156

1113

1.39

3.85

1.4

540.79

692.93

mu/l

0.60

147

1055

Other intervertebral disc disorders

184

810

1.37

3.85

1.4

634.94

679.60

mu/l

0.08

175

766

Injuries to the head

296

1427

1.28

3.81

1.4

552.55

681.90

mu/l

0.58

284

1353

Disorders of eyelid, lacrimal system and orbit

181

1015

1.35

3.71

1.5

1.4

472.69

729.08

mu/l

1.37

172

968

Provisional assignment of new diseases of uncertain etiology

144

1030

1.40

3.70

1.3

1.5

534.77

631.30

mu/l

0.37

137

976

Haemorrhage, not elsewhere classified

5.65

3.66

1.4

584.33

329.00

mu/l

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

561

1.54

3.63

1.5

1.4

613.42

516.71

mu/l

0.34

539

Codes for special purposes

144

1034

1.39

3.63

1.3

1.5

534.77

632.29

mu/l

0.38

137

980

GASTRO-related operations

253

979

1.30

3.59

1.5

1.4

445.12

641.50

mu/l

1.79

244

932

Any gastric operation

253

979

1.30

3.59

1.5

1.4

445.12

641.50

mu/l

1.79

244

932

Soft tissue disorders

302

1228

1.27

3.58

1.5

1.4

441.40

718.41

mu/l

1.92

287

1168

Concussion

132

762

1.41

3.56

1.3

1.4

1053.34

720.07

mu/l

0.32

125

725

Infections with a predominantly sexual mode of transmission

122

855

1.43

3.55

1.3

1.4

395.50

552.59

mu/l

1.99

117

809

Short stature starting before birth

10.35

3.53

1.3

1.5

616.50

363.50

mu/l

—

Other adrenocortical overactivity

10.23

3.51

2.3

1.0

478.83

309.17

mu/l

—

Motor disorders, excluding more controls

5.38

3.50

1.4

1.6

651.33

294.14

mu/l

—

Cardiovascular diseases (excluding rheumatic etc)

239

1062

1.30

3.46

1.3

1.4

474.94

555.35

mu/l

0.87

230

1010

Exposure to other specified factors

205

1440

1.31

3.42

1.3

1.4

597.99

666.98

mu/l

0.28

194

1368

Congenital malformations, deformations and chromosomal abnormalities

189

1363

1.32

3.42

1.3

1.4

606.99

555.87

mu/l

0.16

182

1292

Diseases of inner ear

541

1.52

3.41

1.6

1.5

491.17

851.03

mu/l

0.89

515

Unspecified lump in breast

153

2.03

3.39

1.5

1.4

671.81

440.01

mu/l

0.52

148

Acute alcohol intoxication

319

1.70

3.39

1.3

1.5

471.43

644.63

mu/l

0.39

305

Erosion of teeth , including avohilmo

540

1.52

3.31

1.3

1.4

481.64

483.82

mu/l

0.01

519

Specific development disorders of scholastic skills

126

2.13

3.31

1.4

1.3

596.26

369.89

mu/l

0.86

121

Allergic conjunctivitis

169

1237

1.33

3.26

1.4

622.76

540.68

mu/l

0.47

161

1181

Other strabismus

421

1.57

3.05

1.5

1.4

625.50

492.94

mu/l

0.56

402

Asthma, hospital admissions , main diagnosis only

212

1462

1.28

3.04

1.5

1.4

502.58

668.22

mu/l

1.06

202

1391

Other bacterial diseases

188

968

1.31

3.03

1.4

691.10

733.81

mu/l

0.07

178

919

Injuries to the ankle and foot

209

1452

1.28

3.01

1.4

571.34

676.48

mu/l

0.46

199

1380

Viral infections characterized by skin and mucous membrane lesions

220

1479

1.27

3.00

1.5

1.4

630.23

670.48

mu/l

0.08

208

1406

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

178

863

1.31

2.94

1.4

594.89

518.26

mu/l

0.29

170

821

Other bacterial intestinal infections

251

1.72

2.87

1.3

1.5

438.08

429.45

mu/l

0.04

238

Urticaria and erythema

101

716

1.41

2.86

1.5

1.4

813.74

493.53

mu/l

0.47

683

Desensitization to allergens

136

2.00

2.85

1.3

1.4

753.81

435.91

mu/l

0.88

130

Diabetes medication

251

1192

1.25

2.81

1.3

1.5

524.67

736.94

mu/l

0.94

236

1139

Cerebrovascular diseases

420

1.46

2.77

1.5

835.60

928.66

mu/l

0.07

403

Gingivitis and periodontal diseases

230

942

1.26

2.73

1.5

1.4

423.55

584.50

mu/l

1.60

217

898

Certain infectious and parasitic diseases

180

694

1.30

2.71

1.3

1.4

440.35

602.15

mu/l

1.04

171

661

Anosmia

8.13

2.70

1.0

327.40

1001.17

mu/l

—

Nerve, nerve root and plexus disorders

237

1162

1.25

2.70

1.6

1.4

810.64

686.49

mu/l

0.19

223

1107

Missing teeth due to accident, extraction or parodontitis

533

1.45

2.68

1.3

1.5

445.83

827.07

mu/l

1.00

509

Spondylopathies

132

584

1.35

2.68

1.4

1328.27

712.23

mu/l

0.38

125

553

Benign neoplasm of colon, rectum, anus and anal canal

401

1.49

2.60

1.6

1.5

2422.39

709.24

mu/l

0.58

386

Benign neoplasm: Colon

343

1.56

2.60

1.7

1.4

2293.73

742.82

mu/l

0.40

331

Other diseases of hard tissues of teeth

104

384

1.40

2.58

1.3

1.5

383.05

530.29

mu/l

1.24

365

Other facial nerve disorders

4.02

2.57

1.4

1.6

1059.25

380.90

mu/l

—

Chronic diseases of tonsils and adenoids

219

1108

1.25

2.54

1.4

842.23

599.84

mu/l

0.39

207

1054

Injuries to the thorax

541

1.44

2.52

1.3

1.4

1830.63

672.46

mu/l

0.43

513

Arthropod-borne viral fevers and viral haemorrhagic fevers

194

1.75

2.49

1.5

1.4

484.76

421.75

mu/l

0.29

187

Other obstetric conditions, not elsewhere classified

175

871

1.28

2.47

1.4

601.75

519.64

mu/l

0.30

167

829

Diseases of pulp and periapical tissues, including avohilmo

275

1168

1.22

2.47

1.4

436.87

534.75

mu/l

1.63

258

1113

Diseases of external ear

455

1.47

2.43

1.3

1.4

475.65

446.18

mu/l

0.10

434

Alcohol abuse, main dg

226

1.69

2.42

1.3

1.4

469.70

408.20

mu/l

0.23

218

Acute suppurative otitis media

116

809

1.34

2.42

1.3

1.4

708.42

509.33

mu/l

0.39

110

775

Viral and other specified intestinal infections

108

771

1.35

2.41

1.3

1.4

712.99

476.88

mu/l

0.47

103

735

Sequelae of injuries, of poisoning and of other consequences of external causes

304

1.58

2.40

1.1

1.4

589.56

412.66

mu/l

0.52

293

Cardiovascular diseases

241

1053

1.23

2.39

1.4

445.13

556.76

mu/l

1.49

230

1002

Diseases of middle ear and mastoid

190

1240

1.25

2.38

1.3

1.4

620.77

489.58

mu/l

0.41

177

1178

Shoulder lesions

135

621

1.32

2.37

1.3

1.5

587.63

924.22

mu/l

0.90

129

591

Viral haemorrhagic fevers, not elsewhere classified/unspecified

175

1.77

2.36

1.5

1.4

487.26

420.84

mu/l

0.28

168

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

3.65

2.36

1.5

1.4

593.00

809.50

mu/l

—

Gestational diabetes (for exclusion)

164

897

1.27

2.29

1.4

505.84

539.09

mu/l

0.11

159

853

Diseases of oesophagus, stomach and duodenum

244

1197

1.22

2.27

1.3

1.5

926.02

657.36

mu/l

0.29

228

1140

Abnormal findings on antenatal screening of mother

368

0.51

2.27

1.4

1.5

260.58

587.36

mu/l

4.88

348

Bleeding

134

731

1.30

2.26

1.5

545.30

810.73

mu/l

0.81

128

695

Intracranial trauma

145

795

1.28

2.18

1.3

1.4

1000.98

706.19

mu/l

0.30

137

756

Other acute lower respiratory infections

121

884

1.31

2.15

1.4

417.98

706.33

mu/l

1.40

114

839

Molar incisor enamel hypoplasia, with caries

4.32

2.15

1.2

384.50

380.00

mu/l

—

Unspecified privation

123

1.87

2.11

1.4

738.96

393.72

mu/l

1.36

118

Other disorders of urethra and urinary system

160

917

1.26

2.10

1.4

565.89

711.99

mu/l

0.50

151

875

Specific developmental disorder of motor function

2.96

2.09

1.4

1.2

651.33

378.71

mu/l

—

Excessive earwax

615

1.37

2.09

1.2

1.5

411.28

791.51

mu/l

1.26

586

Acute sinusitis

144

1050

1.27

2.09

1.4

449.40

530.40

mu/l

0.84

137

995

Zoster [herpes zoster]

138

1.81

2.08

1.5

1.4

540.58

415.74

mu/l

0.31

133

Erosion and ectropion of cervix uteri

4.02

2.04

1.3

1.4

255.17

705.47

mu/l

—

All influenza

342

1.49

2.02

1.4

490.63

879.17

mu/l

0.66

330

Fracture of rib(s), sternum and thoracic spine

254

1.58

2.02

1.5

1.4

422.00

520.12

mu/l

0.41

242

Supplementary factors related to causes of morbidity and mortality classified elsewhere

534

1.39

2.00

1.3

1.5

906.91

478.88

mu/l

0.80

511

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

160

1015

1.25

1.99

1.6

1.4

466.45

561.58

mu/l

0.90

155

964

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

184

899

1.23

1.97

1.3

1.5

566.25

638.50

mu/l

0.22

172

858

Intracranial injury

130

965

1.27

1.97

1.3

1.4

609.89

726.46

mu/l

0.25

122

908

Puerperal sepsis

127

1.81

1.93

1.3

1.4

593.43

411.21

mu/l

0.82

121

Pregnancy examination and test

399

1.36

1.93

1.4

1.5

446.97

577.96

mu/l

1.12

379

Rotator cuff syndrome

438

1.36

1.92

1.3

1.5

585.59

1009.10

mu/l

0.78

418

Type 1 diabetes

437

1.42

1.91

1.4

1.5

447.93

492.40

mu/l

0.21

416

Insulin, intermediate and long-acting

656

1.33

1.91

1.3

1.5

404.83

838.81

mu/l

1.56

626

Periapical abscess

645

1.33

1.85

1.4

1.5

369.87

744.29

mu/l

1.35

615

Suppurative and unspecified otitis media

139

983

1.25

1.84

1.3

1.4

648.75

503.20

mu/l

0.34

133

940

Hypoplasia of dental enamel

3.56

1.83

1.2

384.50

471.24

mu/l

—

Malignant neoplasm of breast, ER-negative, including Hilmo

130

1.76

1.83

1.8

1.5

412.96

531.07

mu/l

0.67

125

Other bacterial diseases

218

1153

1.20

1.82

1.4

647.76

725.71

mu/l

0.17

206

1091

Chronic lower respiratory diseases

309

1410

1.17

1.82

1.4

555.79

683.35

mu/l

0.65

295

1338

Other specific joint derangements/joint disorders

219

1182

1.20

1.80

1.5

1.4

459.84

735.71

mu/l

1.67

208

1120

Appendectomy

163

1277

1.22

1.73

1.4

451.62

709.56

mu/l

1.63

156

1210

Motor disorders

2.51

1.73

1.4

1.1

651.33

375.73

mu/l

—

Meralgia paraesthetica

2.93

1.72

1.0

1.3

561.43

419.29

mu/l

—

L04AA Selective immunosuppressants

298

1.48

1.71

1.3

1.5

505.93

439.93

mu/l

0.34

286

Hyperhidrosis

2.30

1.70

1.1

1.6

278.55

420.58

mu/l

1.10

Presence of other devices

155

1.67

1.69

1.2

1.4

458.04

551.82

mu/l

0.22

145

Diseases of the musculoskeletal system and connective tissue

182

752

1.21

1.68

1.4

414.13

677.77

mu/l

1.95

173

712

Acute alcohol intoxication, ICD10

300

1.47

1.67

1.3

1.4

534.84

398.76

mu/l

0.66

288

Renal tubulo-interstitial diseases

190

1181

1.20

1.64

1.4

1.5

553.39

693.64

mu/l

0.42

180

1125

Other arthrosis

347

1.36

1.60

1.4

1.5

517.85

1138.24

mu/l

0.99

328

Anomalies of dental arch relationship, including avohilmo

455

1.35

1.59

1.3

1.4

647.40

498.69

mu/l

0.67

432

Inguinal hernia

538

0.73

1.57

1.6

1.4

389.60

925.59

mu/l

1.56

507

Chronic apical periodontitis

275

1353

1.16

1.53

1.4

1245.76

514.07

mu/l

1.04

262

1284

Diabetes, insulin treatment (Kela reimbursement)

187

946

1.19

1.53

1.3

1.5

570.27

770.73

mu/l

0.61

175

903

Diabetic retinopathy

279

0.65

1.52

1.5

1.3

455.86

1014.88

mu/l

0.83

262

Complications associated with artificial fertilization

2.61

1.51

1.0

1.4

249.14

682.07

mu/l

—

Chronic rhinitis, nasopharyngitis and pharyngitis

528

1.33

1.51

1.6

1.5

417.82

503.69

mu/l

0.53

504

Other fall from one level to another

391

1.38

1.50

1.3

1.4

491.82

445.54

mu/l

0.21

373

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

2.36

1.43

1.2

1.7

452.11

498.22

mu/l

—

Diseases of the ear and mastoid process

297

1302

1.15

1.42

1.4

548.75

708.09

mu/l

0.61

279

1243

Other sexually transmitted chlamydial diseases

237

1.48

1.41

1.3

1.4

455.27

454.42

mu/l

0.00

222

Urticaria

622

1.29

1.41

1.4

940.29

494.05

mu/l

0.54

594

Other diseases of upper respiratory tract

253

1141

1.16

1.39

1.5

1.4

1054.79

593.15

mu/l

0.52

238

1087

Unspecified fall

771

1.25

1.39

1.3

1.4

860.25

690.74

mu/l

0.26

732

Non-invasive ventilation

246

0.58

1.38

1.3

1.5

737.19

730.23

mu/l

0.01

237

Other and unspecified trigeminal disorders

2.96

1.36

1.4

1.5

11766.60

600.06

mu/l

—

Haemorrhoids and perianal venous thrombosis

290

1.41

1.32

1.4

1.5

464.34

1065.26

mu/l

0.86

276

Cardiac arrest

2.45

1.31

1.5

1.3

507.88

550.11

mu/l

—

Undetermined asthma

168

1.55

1.30

2.5

1.4

409.58

416.81

mu/l

0.03

159

Disorders of gallbladder, biliary tract and pancreas

183

983

1.17

1.29

1.5

541.22

760.02

mu/l

0.93

171

936

COPD differential diagnosis

191

816

1.17

1.28

1.4

1.5

453.25

718.35

mu/l

1.71

181

782

ILD differential diagnosis

191

816

1.17

1.28

1.4

1.5

453.25

718.35

mu/l

1.71

181

782

Sub-endpoint used in defining T1D endpoints

466

1.31

1.26

1.4

446.29

508.88

mu/l

0.33

446

Undetermined asthma, excluding more controls

170

1.53

1.25

2.5

1.4

409.58

416.89

mu/l

0.03

161

Pacemaker

148

1.55

1.23

1.5

1.4

395.00

561.46

mu/l

0.44

140

Excluding asthma or asthma-COPD overlap

191

821

1.17

1.21

1.4

1.5

450.72

718.93

mu/l

1.76

181

787

Other arrhythmias

119

744

1.21

1.19

1.5

1.4

554.34

598.56

mu/l

0.13

114

707

Tonsillectomy and adenotomy

201

1213

1.15

1.18

1.4

1308.11

525.51

mu/l

0.77

191

1154

Other joint disorders

259

1202

1.14

1.17

1.5

1.4

425.03

729.31

mu/l

2.17

247

1139

Type 1 diabetes, wide definition, subgroup 1

375

1.33

1.17

1.3

1.5

450.44

508.53

mu/l

0.24

357

Diabetic retinopathy, excluding more controls

216

0.67

1.17

1.5

1.3

482.77

1174.88

mu/l

0.79

203

Paroxysmal tachycardia

256

1.37

1.16

1.6

421.52

426.97

mu/l

0.02

249

Arnold-Chiari syndrome

2.52

1.15

1.2

1.5

683.00

374.60

mu/l

—

Delayed milestone in childhood

2.07

1.15

1.6

1.1

474.88

454.43

mu/l

—

Injuries to the hip and thigh

468

1.28

1.14

1.5

1.4

376.65

689.67

mu/l

0.82

445

Other cataract

226

1.37

1.12

1.5

1.4

404.00

866.09

mu/l

0.93

215

Acute tubulo-interstitial nephritis

126

914

1.19

1.12

1.4

416.22

712.86

mu/l

1.55

121

870

Ventral hernia

175

1.49

1.12

1.4

1.5

371.00

534.29

mu/l

0.62

168

Other condition

200

1.45

1.11

1.3

1.4

1445.63

406.70

mu/l

0.71

194

ILD medications: prednisolone, methylprednisolone, prednisone

264

1308

1.13

1.11

1.5

1.4

541.97

709.16

mu/l

0.87

256

1237

Maternal care for known or suspected abnormality of pelvic organs

629

0.80

1.11

1.3

1.5

303.76

539.92

mu/l

4.48

600

Childhood allergy (age < 16)

612

1.23

1.10

1.4

487.10

488.99

mu/l

0.01

577

All kidney diseases

229

1377

1.14

1.10

1.3

1.4

529.56

700.24

mu/l

0.68

218

1309

Internal derangement of knee

572

1.25

1.09

1.3

1.4

400.82

856.83

mu/l

1.45

544

Asthma and allergy

367

1.32

1.09

1.3

1.4

608.40

526.51

mu/l

0.23

352

Type 1 diabetes, wide definition

389

1.31

1.08

1.3

1.5

475.49

506.80

mu/l

0.12

371

Benign neoplasm of ovary

120

1.58

1.08

1.3

486.03

441.69

mu/l

0.19

115

False labour

739

0.83

1.08

1.2

1.5

623.94

546.64

mu/l

0.15

705

Other pulmonary diagnosis

189

821

1.15

1.07

1.4

1.5

453.86

718.93

mu/l

1.72

179

787

Injuries to the wrist and hand

240

1472

1.13

1.06

1.3

1.4

612.37

668.90

mu/l

0.17

231

1396

Abnormal findings in secretions and smears from cervix uteri vagina vulva

146

945

1.17

1.05

1.6

1.4

476.21

555.66

mu/l

0.70

141

898

Inflammatory disorders of breast

154

1.50

1.03

1.3

1.5

613.78

482.58

mu/l

0.36

147

255

1171

1.13

1.02

1.4

1066.40

605.29

mu/l

0.53

244

1110

Type of accident

474

1.27

1.01

1.3

1.4

967.87

494.27

mu/l

0.69

455

Asthma and allergy, excluding more controls

372

1.30

1.00

1.3

1.4

608.40

526.79

mu/l

0.23

357

Systemic connective tissue disorders

404

1.29

0.99

1.3

1.5

400.22

432.83

mu/l

0.19

383

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

514

1.20

0.98

1.4

1.5

494.63

597.06

mu/l

0.52

490

Cardiac arrhythmias

147

823

1.16

0.98

1.4

483.43

661.88

mu/l

0.92

142

786

Gastrointestinal diseases

184

806

1.14

0.96

1.4

493.39

721.84

mu/l

1.39

177

771

Allergic asthma (mode)

574

1.23

0.94

1.3

1.5

543.85

564.28

mu/l

0.07

550

Type 1 diabetes, strict definition, subgroup 1

197

0.61

0.94

1.2

1.5

400.92

432.34

mu/l

0.16

184

Other congenital malformations of skin

126

1.51

0.91

1.5

795.63

394.49

mu/l

1.17

120

Enlarged lymph nodes

185

1.41

0.89

1.2

1.5

310.81

402.86

mu/l

1.10

176

Arthropathies

264

1204

1.11

0.89

1.5

1.4

410.89

728.25

mu/l

2.36

258

1141

Open wound of ankle and foot

152

1.45

0.87

1.1

1.4

581.27

419.51

mu/l

0.72

145

Suppurative otitis media, unspecified

1.87

0.87

1.1

1.2

463.63

319.08

mu/l

—

Allergic asthma (mode), excluding more controls

580

1.22

0.87

1.3

1.5

543.85

565.93

mu/l

0.07

556

Other systemic involvement of connective tissue (FG)

286

1.31

0.86

1.3

1.5

377.41

425.54

mu/l

0.26

272

Any death

330

0.76

0.85

1.2

1.4

575.03

1147.71

mu/l

0.77

318

Spondyloarthritis

238

1.35

0.85

1.3

1.5

446.00

432.54

mu/l

0.06

227

Nonsuppurative otitis media

656

1.19

0.85

1.4

515.63

496.91

mu/l

0.07

625

Peripheral artery disease

182

1.36

0.84

1.1

1.4

682.13

1560.34

mu/l

0.70

172

Other juvenile arthritis

104

1.54

0.84

2.4

1.3

645.25

449.07

mu/l

0.70

Atypical facial pain

1.78

0.84

1.8

1.6

644.88

482.02

mu/l

—

Insulin, combination of fast acting with intermediate-acting or long-acting

736

1.18

0.84

1.3

1.5

398.50

805.87

mu/l

1.68

701

Juvenile arthritis (FINNGEN)

121

1.49

0.82

2.6

1.4

603.78

431.78

mu/l

0.67

114

ILD medications

278

1369

1.10

0.81

1.5

1.4

526.03

695.72

mu/l

0.95

269

1294

Type 1 diabetes, strict definition

200

0.65

0.80

1.2

1.5

503.00

439.49

mu/l

0.21

187

Coxibs

303

1.22

0.80

1.3

1.5

405.56

768.90

mu/l

1.99

285

Chronic periodontitis, including avohilmo

172

1023

1.13

0.79

1.4

1.5

491.23

786.21

mu/l

1.54

163

974

External causes of morbidity and mortality

168

745

1.13

0.78

1.4

1.5

490.35

571.88

mu/l

0.51

158

715

Injuries to the knee and lower leg

282

1427

1.10

0.78

1.4

571.76

679.68

mu/l

0.43

268

1357

Postpartum haemorrhage due to anatomy

359

1.26

0.75

1.1

1.4

1198.07

389.28

mu/l

0.80

345

Periodontitis

172

1026

1.12

0.75

1.4

1.5

490.63

785.12

mu/l

1.55

163

977

Falls/tendency to fall

278

1272

1.09

0.73

1.4

526.63

696.92

mu/l

0.89

265

1208

Palatinal maxillary operation

2.01

0.73

1.0

1.1

524.60

448.97

mu/l

—

Presence of other functional implants

295

0.78

0.72

1.2

1.4

448.45

1161.53

mu/l

1.08

281

Basal cell carcinoma

169

1.31

0.71

1.2

1.4

426.31

848.84

mu/l

1.08

161

197

1076

1.11

0.70

1.3

1.4

594.61

605.25

mu/l

0.05

182

1025

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

197

1076

1.11

0.70

1.3

1.4

594.61

605.25

mu/l

0.05

182

1025

Accidents

201

908

1.11

0.70

1.4

1.5

460.00

646.08

mu/l

1.32

192

866

Abnormalities of forces of labour

205

0.68

0.69

1.3

1.6

486.71

458.99

mu/l

0.06

192

COPD/asthma related infections

236

1076

1.10

0.69

1.4

445.90

605.25

mu/l

1.74

224

1025

COPD/asthma/ILD related infections

236

1076

1.10

0.69

1.4

445.90

605.25

mu/l

1.74

224

1025

Other systemic involvement of connective tissue

301

1.26

0.69

1.3

1.5

377.41

427.36

mu/l

0.27

284

Diseases of appendix

163

1318

1.11

0.69

1.4

465.14

724.87

mu/l

1.64

155

1248

Conductive and sensorineural hearing loss

100

585

1.15

0.68

1.3

1.5

384.62

867.30

mu/l

1.62

559

Appendicitis, broad definition

162

1315

1.11

0.68

1.4

467.60

726.06

mu/l

1.62

154

1245

DVT of lower extremities

127

1.42

0.67

1.7

1.5

488.44

428.18

mu/l

0.16

122

Other malignant neoplasms of skin (=non-melanoma skin cancer)

176

1.29

0.66

1.2

1.4

430.48

829.98

mu/l

1.06

168

Insulin medication

695

1.15

0.65

1.3

1.5

398.50

835.02

mu/l

1.72

662

Diabetic maculopathy, excluding more controls

104

1.44

0.62

1.3

1.4

400.19

395.24

mu/l

0.01

Chondropathies

217

1.29

0.61

1.4

1.5

632.82

401.39

mu/l

0.86

209

Finngen Rheumatological endpoints

205

1274

0.91

0.60

1.4

426.63

725.81

mu/l

2.20

198

1205

Acute appendicitis, no complications

129

1150

1.12

0.59

1.4

461.55

704.59

mu/l

1.24

122

1090

Childhood asthma (age<16)

445

1.17

0.58

1.3

1.4

557.01

515.56

mu/l

0.19

428

Childhood asthma (age<16), excluding more controls

445

1.17

0.58

1.3

1.4

557.01

515.56

mu/l

0.19

428

Other and unspecified tonsillitis

118

886

1.12

0.57

1.5

1.4

1052.68

558.20

mu/l

0.47

111

842

Diabetic maculopathy

195

0.72

0.56

1.3

400.19

485.44

mu/l

0.28

184

Other complications of labour and delivery, not elsewhere classified

513

1.16

0.55

1.3

1.5

291.14

527.28

mu/l

9.22

488

Herpesviral [herpes simplex] infections

513

1.17

0.55

1.3

1.4

1012.56

502.01

mu/l

0.42

491

Acute appendicitis

152

1291

1.10

0.55

1.3

1.4

475.99

727.33

mu/l

1.48

145

1222

Maternal care related to the fetus and amniotic cavity and possible delivery problems

123

803

0.90

0.54

1.3

1.5

538.57

545.80

mu/l

0.02

116

763

Malignant neoplasm of prostate

0.69

0.54

1.2

1.4

398.73

970.96

mu/l

0.77

Diabetic retinopathy, strict definition

240

0.77

0.52

1.4

1.3

411.19

972.83

mu/l

0.72

226

Malignant neoplasm of bronchus and lung, including Hilmo

0.61

0.52

1.2

1.3

292.83

646.85

mu/l

—

Calcific aortic valvular stenosis, operated

105

1.39

0.52

2.6

1.2

492.33

564.04

mu/l

0.11

Calcific aortic valvular stenosis

105

1.39

0.52

2.6

1.2

492.33

564.04

mu/l

0.11

Operations 2 for CAVS

105

1.38

0.52

2.6

1.2

492.33

564.04

mu/l

0.11

Calcific aortic valvular stenosis, diagnosis (helper)

105

1.38

0.52

2.6

1.2

492.33

564.04

mu/l

0.11

Other respiratory diseases principally affecting the interstitium

1.41

0.50

1.2

1.5

505.15

405.71

mu/l

0.25

Tooth agenesis EXCLUDE clefts and syndromes

118

1.36

0.50

1.3

1.4

597.87

431.50

mu/l

0.44

113

Calcific aortic valvular stenosis, including rheumatic fever

106

1.37

0.49

2.6

1.2

492.33

563.96

mu/l

0.11

100

Embedded teeth, including avohilmo

307

1.21

0.49

1.2

1.4

503.30

518.74

mu/l

0.06

289

Female genital prolapse

116

1.27

0.48

1.4

1.6

890.23

817.92

mu/l

0.08

111

Pedal cyclist injured in other and unspecified transport accidents

154

1.30

0.48

1.6

1.4

348.80

411.62

mu/l

0.61

148

Injuries to the elbow and forearm

147

1183

1.09

0.47

1.4

913.74

627.19

mu/l

0.65

134

1131

Pregnancy with abortive outcome

178

858

1.08

0.45

1.3

1.4

428.47

554.12

mu/l

2.02

167

816

All influenza (not pneumonia)

210

1.24

0.44

1.2

1.4

553.65

515.83

mu/l

0.08

204

Other maternal disorders predominantly related to pregnancy

160

924

1.09

0.44

1.4

431.25

557.91

mu/l

1.88

152

875

Pruritus

130

1.31

0.43

1.2

1.4

284.65

409.74

mu/l

1.54

125

Dental caries, including avohilmo

122

568

1.10

0.43

1.3

1.5

399.84

526.64

mu/l

1.16

116

544

Other external causes of accidental injury

195

908

1.08

0.42

1.4

1.5

469.95

646.08

mu/l

1.22

187

866

Type1 diabetes, definitions combined, early onset

184

0.76

0.42

1.3

1.4

569.50

412.08

mu/l

0.62

175

Colorectal adenocarcinoma

0.64

0.42

1.2

1.4

5492.33

674.99

mu/l

—

Dislocation, sprain and strain of joints and ligaments of knee

142

1206

1.09

0.42

1.3

1.4

443.33

701.77

mu/l

1.64

132

1143

Multiple delivery

195

0.77

0.41

1.4

1.6

372.13

619.78

mu/l

1.04

180

Diseases of pulp and periapical tissues and dental caries

109

507

1.10

0.41

1.2

1.5

385.89

490.42

mu/l

1.26

104

487

Failed induction of labour

231

1.21

0.41

1.1

1.5

302.14

484.97

mu/l

3.85

218

Contact with and exposure to communicable diseases

1021

0.91

0.41

1.2

1.4

474.01

524.07

mu/l

0.24

976

Malignant neoplasm of prostate, including Hilmo

103

0.75

0.40

1.2

1.4

369.08

935.38

mu/l

0.81

Other respiratory disorders and diseases

123

1.30

0.40

1.5

1.4

436.06

410.38

mu/l

0.07

118

Other diseases of the respiratory system

123

1.30

0.40

1.5

1.4

436.06

410.38

mu/l

0.07

118

Respiratory insufficiency

1.47

0.40

2.0

1.5

522.40

327.47

mu/l

—

Hernia

143

1034

0.93

0.38

1.4

493.29

754.37

mu/l

1.19

136

982

Benign lipomatous neoplasm

270

1.19

0.38

2.2

1.4

505.03

412.61

mu/l

0.40

256

Valvular operations

1.34

0.38

1.6

1.2

508.00

651.72

mu/l

—

Colorectal cancer

110

0.71

0.37

1.1

1.4

4197.75

661.84

mu/l

—

102

Injury, poisoning and certain other consequences of external causes

138

642

1.08

0.34

1.4

1.5

462.00

547.00

mu/l

0.49

132

615

Non-Hodgkin lymphoma, all, including Hilmo

1.37

0.34

1.3

1.4

277.60

695.06

mu/l

—

malignant neoplasm of male genital organs

116

0.79

0.34

1.1

1.4

340.47

860.18

mu/l

0.86

109

Pneumonia, organism unspecified

181

1192

1.06

0.34

1.3

1.4

606.01

732.82

mu/l

0.49

165

1134

Spondylopathies (FG)

219

1.19

0.33

1.2

1.5

469.15

416.44

mu/l

0.22

208

Malignant neoplasm of colon, including Hilmo

0.67

0.32

1.2

1.5

5378.17

714.08

mu/l

—

Acute appendicitis, with complications

193

1.19

0.30

1.1

1.5

552.57

411.42

mu/l

0.60

184

Contraceptive management

622

1.08

0.30

1.2

1.5

393.84

589.21

mu/l

2.50

593

Other obstetric trauma

141

0.78

0.29

1.3

1.6

441.55

486.10

mu/l

0.12

130

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

107

0.75

0.29

1.4

1.5

417.38

615.35

mu/l

—

101

Other keratitis

158

1.20

0.28

1.1

1.5

619.75

402.86

mu/l

0.27

150

Type 1 diabetes, strict (exclude DM2)

215

0.83

0.27

1.2

1.4

459.22

429.14

mu/l

0.14

202

Noninfective enteritis and colitis

837

1.07

0.25

1.3

1.4

454.21

609.23

mu/l

0.90

796

Scoliosis

192

0.83

0.25

1.3

1.4

476.88

458.68

mu/l

0.04

183

Inflammatory bowel disease treatment related agents

244

1423

0.96

0.25

1.5

1.4

497.95

696.74

mu/l

1.24

238

1345

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

125

0.79

0.25

1.3

1.5

365.90

621.07

mu/l

—

117

Malignant neoplasm of bronchus and lung

0.72

0.24

1.2

1.3

292.83

722.56

mu/l

—

Secondary uncertain malignant neoplasm

0.71

0.24

1.7

1.4

512.83

390.52

mu/l

—

Other/unspecified seropositive rheumatoid arthritis

201

0.85

0.23

1.4

1.5

551.18

434.13

mu/l

0.35

194

Other disorders of ear

144

894

1.05

0.23

1.4

1.5

394.80

774.37

mu/l

2.06

134

849

Chronic sinusitis

706

1.08

0.23

1.6

1.5

456.32

558.63

mu/l

0.74

673

Influenza and pneumonia

237

1447

1.04

0.23

1.4

575.23

680.98

mu/l

0.51

221

1380

Acute and subacute iridocyclitis

219

1.14

0.22

1.2

1.4

540.87

416.21

mu/l

0.65

210

Crohn's disease of small intestine

107

1.22

0.21

1.4

521.00

398.14

mu/l

0.48

102

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

198

0.86

0.20

1.4

551.18

436.23

mu/l

0.34

191

Congenital malformations of eye, ear, face and neck

145

1.17

0.20

1.4

735.29

379.04

mu/l

1.14

139

Polyarthrosis

1.23

0.20

1.0

1.5

313.36

528.08

mu/l

1.75

Type 1 diabetes, definitions combined

217

0.87

0.19

1.2

1.4

526.00

431.49

mu/l

0.43

204

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

106

1003

1.05

0.18

1.5

1.4

548.15

517.07

mu/l

0.12

100

957

Maternal care for other known or suspected fetal problems

102

680

0.95

0.18

1.3

1.5

674.42

524.64

mu/l

0.33

648

Seropositive rheumatoid arthritis, wide

206

0.87

0.18

1.3

1.5

529.00

428.99

mu/l

0.31

199

Oral corticosteroids

225

1291

1.03

0.17

1.5

1.4

506.61

721.09

mu/l

1.21

219

1219

Medical abortion

148

836

0.96

0.17

1.4

424.62

557.00

mu/l

1.82

136

795

Later onset COPD, excluding more controls

0.72

0.17

1.2

1.3

384.40

810.04

mu/l

—

Malignant neoplasm of colon

0.76

0.17

1.2

1.6

6421.80

479.68

mu/l

—

Congenital malformations and deformations of the musculoskeletal system

204

1.12

0.16

1.1

1.4

371.61

418.95

mu/l

0.29

195

Other heart diseases, wide

199

1176

1.03

0.16

1.5

1.4

503.32

611.79

mu/l

0.68

193

1113

Anterior Iridocyclitis

234

1.11

0.16

1.2

1.4

529.84

409.47

mu/l

0.65

225

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

208

1311

1.03

0.16

1.3

1.4

762.99

681.57

mu/l

0.16

202

1243

Artificial joint operation, meniscal resection

100

680

0.95

0.15

1.5

518.93

845.59

mu/l

0.97

647

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

202

1334

1.03

0.15

1.3

1.4

588.26

702.37

mu/l

0.50

186

1273

1.21

0.15

1.2

1.4

574.10

676.57

mu/l

—

Special screening examination for other diseases and disorders

149

1.14

0.15

1.6

1.4

855.76

450.67

mu/l

1.65

142

Fracture of femur

127

1.14

0.14

1.8

1.4

365.90

426.50

mu/l

0.26

119

Placenta praevia

150

0.87

0.14

1.2

1.7

431.69

494.04

mu/l

0.19

142

Family history of malignant neoplasm

169

1.12

0.14

1.4

2213.47

429.31

mu/l

0.54

159

Arthrosis

105

552

1.04

0.14

1.4

504.53

977.66

mu/l

1.27

100

523

Disorders of synovium and tendon

805

1.04

0.14

1.4

700.18

849.54

mu/l

0.23

766

Tooth eruption problems

588

0.94

0.13

1.4

438.13

500.14

mu/l

0.47

554

Hallux valgus (acquired)

212

0.92

0.13

2.0

1.5

831.48

541.07

mu/l

0.41

204

Persons with potential health hazards related to communicable diseases

112

1152

0.96

0.13

1.2

1.4

455.28

519.97

mu/l

0.41

104

1101

Ulcerative rectosigmoiditis

109

0.83

0.13

1.2

1.4

333.00

418.89

mu/l

—

104

Crohn disease (strict definition, require KELA, min 2 HDR)

110

0.82

0.13

1.4

504.44

390.96

mu/l

—

105

Any event in cancer register

184

1053

1.03

0.12

1.5

1.4

474.25

608.68

mu/l

1.20

179

999

Pneumonias (Asthma/COPD co-morbidities)

211

1381

1.03

0.12

1.3

1.4

589.12

691.61

mu/l

0.45

195

1316

Caries of dentine, including avohilmo

135

668

1.03

0.11

1.3

1.4

388.23

509.62

mu/l

1.39

129

637

Heterophoria

143

1.12

0.11

1.1

1.4

630.94

379.65

mu/l

0.68

138

All pneumoniae

213

1390

1.02

0.11

1.3

1.4

585.45

689.28

mu/l

0.46

197

1325

Seropositive rheumatoid arthritis

197

0.91

0.10

1.3

1.5

529.00

424.05

mu/l

0.33

190

Fall on same level

269

1440

1.02

0.10

1.4

603.26

671.66

mu/l

0.22

256

1367

Asthma/COPD (KELA code 203)

209

1404

1.02

0.09

1.5

1.4

609.42

685.09

mu/l

0.29

202

1333

Iridocyclitis

273

1.06

0.08

1.3

1.4

538.51

419.39

mu/l

0.73

260

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

166

1.08

0.07

1.9

1.6

437.28

431.65

mu/l

0.02

160

Injuries to the shoulder and upper arm

133

1095

0.98

0.07

1.5

1.4

964.43

676.86

mu/l

0.49

124

1039

Peritonsillar abscess

459

0.96

0.07

1.2

1.4

499.02

515.89

mu/l

0.06

442

Lung cancer and mesothelioma

1.02

0.07

1.6

1.4

303.38

720.74

mu/l

—

Methotrexate

147

1.09

0.07

2.0

1.4

486.50

436.66

mu/l

0.13

140

Malignant neoplasm of respiratory system and intrathoracic organs

0.87

0.06

1.6

1.4

313.67

624.10

mu/l

—

Sulfonylureas

121

0.92

0.06

1.1

1.3

330.07

1874.79

mu/l

0.95

112

Insulin, fast-acting (human)

247

1.05

0.05

1.3

1.5

484.04

441.19

mu/l

0.14

234

Labour and delivery complicated by fetal stress [distress]

104

667

1.02

0.05

1.3

1.5

639.82

529.33

mu/l

0.25

634

Crohn disease (strict definition, require KELA)

110

0.91

0.05

1.4

462.20

390.96

mu/l

—

105

Artrosis, including avohilmo

137

761

0.99

0.04

1.6

1.5

541.43

840.34

mu/l

0.98

130

725

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

151

955

1.01

0.03

1.4

1.5

463.55

785.21

mu/l

1.59

143

907

Fracture of forearm

837

0.98

0.03

1.4

1.5

762.45

455.25

mu/l

0.75

801

Diseases of the respiratory system

137

679

1.01

0.02

1.3

1.5

389.31

623.17

mu/l

2.06

130

650

Striking against or struck by other objects

687

0.99

0.01

1.3

1.4

464.96

511.22

mu/l

0.23

657

Deep endometriosis

146

0.96

0.00

1.1

1.5

201.76

450.00

mu/l

5.73

141

Bitten or struck by other mammals

216

0.97

0.00

1.2

1.5

520.64

395.97

mu/l

0.56

203

Cholelithiasis, broad definition with cholecystitis

130

875

1.00

0.00

1.6

1.5

526.29

748.30

mu/l

0.84

125

832

Other Crohn's disease

111

0.99

0.00

1.8

1.4

503.45

419.97

mu/l

0.25

106

Atherosclerosis, excluding cerebral and coronary sclerosis

153

0.98

0.00

1.2

1.4

473.16

1737.68

mu/l

0.98

145

Aortic aneurysm

131

0.97

0.00

1.1

1.5

276.08

534.49

mu/l

0.85

126

Presence of cardiac and vascular implants and grafts

207

1.01

0.00

1.5

1.4

386.64

1468.77

mu/l

1.17

193

Mucinous and mucinous cystic tumor, including Hilmo

0.00

0.0

1.4

—

454.20

—

Pectus excavatum

0.00

0.0

1.2

—

339.22

—

Oral lichen planus and hypothyroidism or thyroxine medication

0.00

0.0

1.1

—

407.88

—

Systemic sclerosis,strict definition

0.00

0.0

1.2

—

409.80

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

0.92

-0.00

1.1

1.5

383.44

663.55

mu/l

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

-0.00

0.0

1.0

—

435.50

—

Other autoimmune haemolytic anaemias

0.00

-0.00

0.0

1.5

—

513.17

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

120

1.00

-0.00

1.3

1.4

407.33

411.02

mu/l

0.01

115

Non-small cell lung cancer, including Hilmo

0.88

-0.00

1.2

1.3

292.83

762.39

mu/l

—

Squamous cell neoplasms and carcinoma of cervix

0.00

-0.00

0.0

1.2

—

409.80

—

Posteruptive colour changes of dental hard tissues

0.00

-0.00

0.0

1.7

—

375.86

—

Malignant neoplasm of bone and articular cartilage of limbs

0.00

-0.00

0.0

1.3

—

395.33

—

Isolated patent ductus arteriosus

0.00

-0.00

0.0

1.5

—

339.50

—

Other congenital musculoskeletal deformities

0.00

-0.00

0.0

1.4

—

423.20

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

-0.00

0.0

1.4

—

259.20

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Prolactin monomeric [Units/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS